PAPER Kim S, Chang KA, Kim JA, Park HG, Ra JC, Kim HS, Suh YH
SEARCH RESULTS
329939 RESULTS
PAPER Kraska A, Santin MD, Dorieux O, Joseph-Mathurin N, Bourrin E, Petit F, Jan C, Chaigneau M, Hantraye P, Lestage P, Dhenain M
In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin.
PLoS One. 2012;7(9):e46196. PubMed: 23049978PAPER Canuet L, Tellado I, Couceiro V, Fraile C, Fernandez-Novoa L, Ishii R, Takeda M, Cacabelos R
Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study.
PLoS One. 2012;7(9):e46289. PubMed: 23050006PAPER Petri S, Körner S, Kiaei M
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS.
Neurol Res Int. 2012;2012:878030. PubMed: 23050144PAPER Martínez-Sánchez F, Meilán JJ, García-Sevilla J, Carro J, Arana JM
Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects.
Neurologia. 2012 Oct 6; PubMed: 23046975PAPER Pepeu G, Giovannini MG, Bracco L
Effect of cholinesterase inhibitors on attention.
Chem Biol Interact. 2012 Oct 6; PubMed: 23047023PAPER Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A
Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease.
J Alzheimers Dis. 2012 Oct 9; PubMed: 23047370PAPER Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A
Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
J Alzheimers Dis. 2013;33(4):929-39. PubMed: 23047371PAPER Kopeikina KJ, Polydoro M, Tai HC, Yaeger E, Carlson GA, Pitstick R, Hyman BT, Spires-Jones TL
Synaptic alterations in the rTg4510 mouse model of tauopathy.
J Comp Neurol. 2013 Apr 15;521(6):1334-53. PubMed: 23047530PAPER Jeppsson F, Eketjäll S, Janson J, Karlström S, Gustavsson S, Olsson LL, Radesäter AC, Ploeger B, Cebers G, Kolmodin K, Swahn BM, von Berg S, Bueters T, Fälting J
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease.
J Biol Chem. 2012 Nov 30;287(49):41245-57. PubMed: 23048024PAPER Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, Jackson GR, Kayed R
Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau.
Sci Rep. 2012;2:700. PubMed: 23050084Expanding the Network, DIAN Starts Showing Longitudinal Data
CONFERENCE COVERAGE 2012-10-11 Conference Coverage On September 27th, researchers, participants, and other stakeholders in the Dominantly Inherited Alzheimer Network (DIAN) gathered at the network’s hub at Washington University, St. Louis, Missouri. They spent a moment basking in pride
PAPER Hoban DB, Connaughton E, Connaughton C, Hogan G, Thornton C, Mulcahy P, Moloney TC, Dowd E
Further characterisation of the LPS model of Parkinson's disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.
Brain Behav Immun. 2013 Jan;27(1):91-100. PubMed: 23044176PAPER Chen X, Zhang X, Li C, Guan T, Shang H, Cui L, Li XM, Kong J
S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
J Neurochem. 2013 Jan;124(1):45-58. PubMed: 23043510PAPER Gunderson WA, Hernández-Guzmán J, Karr JW, Sun L, Szalai VA, Warncke K
Local structure and global patterning of Cu2+ binding in fibrillar amyloid-β [Aβ(1-40)] protein.
J Am Chem Soc. 2012 Nov 7;134(44):18330-7. PubMed: 23043377Current Filters
No filters selected